Healthcare provider profile · identity verified

Michele R Tschopp, MD

Internal Medicine · WAUWATOSA, WI · NPI 1457386849

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	702	192
Amlodipine Besylate	Amlodipine Besylate	603	153
Levothyroxine Sodium	Levothyroxine Sodium	400	95
Metoprolol Succinate	Metoprolol Succinate	351	86
Losartan Potassium	Losartan Potassium	326	89
Omeprazole	Omeprazole	310	80
Lisinopril	Lisinopril	284	76
Metformin Hcl	Metformin Hcl	244	77
Simvastatin	Simvastatin	227	60
Eliquis	Apixaban	215	36
Rosuvastatin Calcium	Rosuvastatin Calcium	187	54
Pantoprazole Sodium	Pantoprazole Sodium	175	43
Sertraline Hcl	Sertraline Hcl	171	31
Hydrochlorothiazide	Hydrochlorothiazide	152	44
Furosemide	Furosemide	141	41
Gabapentin	Gabapentin	140	33
Albuterol Sulfate Hfa	Albuterol Sulfate	124	38
Potassium Chloride	Potassium Chloride	123	39
Metoprolol Tartrate	Metoprolol Tartrate	106	25
Alendronate Sodium	Alendronate Sodium	83	24
Trazodone Hcl	Trazodone Hcl	81	25
Pravastatin Sodium	Pravastatin Sodium	76	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	69	18
Buspirone Hcl	Buspirone Hcl	67	11
Allopurinol	Allopurinol	64	18
Montelukast Sodium	Montelukast Sodium	64	18
Famotidine	Famotidine	63	19
Clopidogrel	Clopidogrel Bisulfate	62	20
Lorazepam	Lorazepam	61	16
Arnuity Ellipta	Fluticasone Furoate	60	suppressed
Citalopram Hbr	Citalopram Hydrobromide	59	13
Fluticasone Propionate	Fluticasone Propionate	59	22
Jardiance	Empagliflozin	56	14
Tramadol Hcl	Tramadol Hcl	55	14
Bupropion Hcl Sr	Bupropion Hcl	52	11
Glimepiride	Glimepiride	52	13
Venlafaxine Hcl Er	Venlafaxine Hcl	52	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	13
Warfarin Sodium	Warfarin Sodium	50	14
Irbesartan	Irbesartan	49	suppressed
Metformin Hcl Er	Metformin Hcl	49	16
Mirtazapine	Mirtazapine	48	13
Tizanidine Hcl	Tizanidine Hcl	48	17
Enalapril Maleate	Enalapril Maleate	47	11
Tamsulosin Hcl	Tamsulosin Hcl	46	14
Duloxetine Hcl	Duloxetine Hcl	45	13
Valacyclovir	Valacyclovir Hcl	44	16
Mounjaro	Tirzepatide	43	suppressed
Ozempic	Semaglutide	43	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	41	13
Candesartan Cilexetil	Candesartan Cilexetil	40	11
Atenolol	Atenolol	38	11
Meloxicam	Meloxicam	37	13
Levetiracetam	Levetiracetam	36	suppressed
Prednisone	Prednisone	33	15
Xarelto	Rivaroxaban	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Carvedilol	Carvedilol	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	26
Ezetimibe	Ezetimibe	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Amoxicillin	Amoxicillin	27	20
Glipizide Er	Glipizide	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	22
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Spironolactone	Spironolactone	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Lovastatin	Lovastatin	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Azithromycin	Azithromycin	19	15
Bumetanide	Bumetanide	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Diazepam	Diazepam	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Baclofen	Baclofen	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Nystatin	Nystatin	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Cephalexin	Cephalexin	15	12
Clonazepam	Clonazepam	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	12
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Nystop	Nystatin	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Ramelteon	Ramelteon	14	suppressed
Valsartan	Valsartan	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Fosinopril Sodium	Fosinopril Sodium	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error